Novel molecule created in Cuba receives patent in New Zealand
Wellington, June 25th, 2024.- JM-20, a molecule developed by Cuba's Center for Research and Development of Medicines (CIDEM), was patented in New Zealand to be used to treat Parkinson's disease.
The Biotechnological and Pharmaceutical Industries Group, BioCubaFarma, informed on its Facebook profile that JM-20 can also be used for neuropathic pain and different kinds of dementia, such as Alzheimer’s disease and vascular dementia.